Picture of Ultimovacs ASA logo

ULTIo Ultimovacs ASA Balance Sheet

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Ultimovacs ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments405448579430270
Net Total Receivables0.5640.7491.141.281.1
Prepaid Expenses
Total Other Current Assets
Total Current Assets408449582436272
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment4.064.012.165.663.67
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets478530656510349
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities20.327.550.945.956.1
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities33.441.362.460.369.6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity445488593449279
Total Liabilities & Shareholders' Equity478530656510349
Total Common Shares Outstanding